PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,661 | +23.5% | 2,578 | 0.0% | 0.00% | +100.0% |
| Q2 2023 | $2,965 | -21.8% | 2,578 | -27.9% | 0.00% | -50.0% |
| Q1 2023 | $3,793 | -38.8% | 3,578 | -12.3% | 0.00% | -33.3% |
| Q4 2022 | $6,199 | -22.5% | 4,078 | +1.8% | 0.00% | -40.0% |
| Q3 2022 | $8,000 | +33.3% | 4,006 | -7.0% | 0.01% | +25.0% |
| Q2 2022 | $6,000 | -62.5% | 4,306 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $16,000 | -30.4% | 4,306 | -6.5% | 0.01% | -38.5% |
| Q3 2021 | $23,000 | -23.3% | 4,606 | 0.0% | 0.01% | -18.8% |
| Q2 2021 | $30,000 | -6.2% | 4,606 | 0.0% | 0.02% | -11.1% |
| Q1 2021 | $32,000 | -27.3% | 4,606 | +5.6% | 0.02% | -41.9% |
| Q4 2020 | $44,000 | +193.3% | 4,360 | -5.2% | 0.03% | +63.2% |
| Q1 2020 | $15,000 | – | 4,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |